Mechanism of action of an lncRNA for directing muscle differentiation
lncRNA指导肌肉分化的作用机制
基本信息
- 批准号:9914219
- 负责人:
- 金额:$ 12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2021-03-14
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdoptionAttentionBackBindingBiologyCell physiologyChromatinChronicCollaborationsDNAFutureGene ExpressionGene Expression RegulationGenetic TranscriptionGenomeGenomicsHumanInjuryInvestigationLaboratoriesMapsMessenger RNAMicroRNAsMolecularMusMuscleMuscle FibersMyoD ProteinMyoblastsMyogeninOpen Reading FramesPathway interactionsPlayProteinsRNAReagentRegenerative MedicineRegulationRegulator GenesRoleSiteSkeletal MuscleSpecificityStructureSystemTestingTherapeuticUntranslated RNAbasecell typechromatin isolation by RNA purification sequencingexperimental studygenome-wideinhibitor/antagonistmutantmyogenesisnoveloperationoverexpressionprogramspromoterprotein complexpublic health relevanceskeletalskeletal muscle differentiationstem cellssuccessthree dimensional structuretranscription factor
项目摘要
DESCRIPTION (provided by applicant): Long noncoding RNAs (lncRNAs) are noncoding long (>100 bases) single- stranded RNAs that have burst onto the scene as major regulators of gene expression. MicroRNAs, are about 22 base long single-stranded RNAs that came to the fore about a decade back and this laboratory has been among the pioneers that demonstrated the roles of several microRNAs in the differentiation of skeletal muscle myoblasts to myotubes. We now propose to use our expertise in the role of RNAs in muscle differentiation to determine the mechanism by which one particular muscle- differentiation-induced (MDI) lncRNA, MUNC, regulates gene expression and promotes muscle differentiation. Aim 1 will test the hypothesis that MUNC is essential for muscle differentiation because of its role in either regulating the binding or the expression of critical myogenic transcription factors as a constituent of novel protein complexes involved in gene regulation. Aim 2 will carry out structure function studies on mouse and human MUNC to test the hypothesis that evolutionarily conserved domains exist in this lncRNA that are critical for its mechanism of action. Aim 3 will identify new protein and DNA partners of MUNC to identify functions of MUNC independent of Myogenic transcription factors. This Aim will also identify additional lncRNAs that are induced during muscle differentiation and integrate their role in differentiation with that of MUNC and MyoD. This is an exciting project that involves the collaboration of a molecular biologist with a skeletal muscle physiologist. It wil use new experimental reagents such as lncRNAs and state-of-the-art approaches like ChIRP. LC-MS-MS, SILAC and ChiRP-seq to discover the mechanism of action of one lncRNA in control of cell-type specificity. Since our preliminary results identify tens of novel lncRNAs induced during differentiation, at least some of which already implicated in differentiation, success of this project will launch a prolonged investigation of several lncRNAs in this very important paradigm of differentiation.
描述(申请人提供):长非编码RNA(LncRNAs)是非编码的长(100个碱基)单链RNA,作为基因表达的主要调节因子而突然出现。MicroRNAs是大约十年前出现的大约22个碱基长的单链RNA,这个实验室是证明几个microRNAs在骨骼肌成肌细胞分化为肌管中的作用的先驱之一。我们现在建议利用我们在RNA在肌肉分化中的作用方面的专业知识来确定一种特定的肌肉分化诱导(MDI)lncRNA,MUNC,通过其调节基因表达和促进肌肉分化的机制。目的1验证MUNC对肌肉分化是必不可少的这一假设,因为它作为参与基因调控的新蛋白复合体的组成部分,调节关键的生肌转录因子的结合或表达。目的2对小鼠和人的MUNC进行结构功能研究,以验证该lncRNA中存在进化保守结构域的假设,这些结构域对其作用机制至关重要。目的3将寻找新的MUNC蛋白和DNA合作伙伴,以确定MUNC的独立于肌源性转录因子的功能。这一目标还将识别在肌肉分化过程中诱导的其他lncRNAs,并将它们在分化中的作用与MUNC和MyoD结合起来。这是一个令人兴奋的项目,涉及一名分子生物学家和一名骨骼肌生理学家的合作。它将使用新的实验试剂,如lncRNA和最先进的方法,如chirp。LC-MS-MS、SILAC和Chirp-seq,以发现一个lncRNA在控制细胞类型特异性方面的作用机制。由于我们的初步结果发现了在分化过程中诱导的数十个新的lncRNAs,其中至少有一些已经与分化有关,该项目的成功将启动对这一非常重要的分化范式中的几个lncRNAs的长期研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anindya Dutta其他文献
Anindya Dutta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anindya Dutta', 18)}}的其他基金
Involvement of Noncanonical Short RNAs in gene repression through the RNA-induced-silencing complex
非规范短 RNA 通过 RNA 诱导沉默复合物参与基因抑制
- 批准号:
10701797 - 财政年份:2022
- 资助金额:
$ 12万 - 项目类别:
Studies on ORC and double strand DNA break repair
ORC与双链DNA断裂修复的研究
- 批准号:
10377840 - 财政年份:2021
- 资助金额:
$ 12万 - 项目类别:
Studies on ORC and double strand DNA break repair
ORC与双链DNA断裂修复的研究
- 批准号:
10555198 - 财政年份:2021
- 资助金额:
$ 12万 - 项目类别:
Studies on ORC and double strand DNA break repair
ORC与双链DNA断裂修复的研究
- 批准号:
10328884 - 财政年份:2021
- 资助金额:
$ 12万 - 项目类别:
Mechanism of action of an lncRNA for directing muscle differentiation
lncRNA指导肌肉分化的作用机制
- 批准号:
10396900 - 财政年份:2016
- 资助金额:
$ 12万 - 项目类别:
Effect of anti-S phase agents on human chromosomes
抗S期药物对人类染色体的影响
- 批准号:
8436839 - 财政年份:2013
- 资助金额:
$ 12万 - 项目类别:
Effect of anti-S phase agents on human chromosomes
抗S期药物对人类染色体的影响
- 批准号:
8608500 - 财政年份:2013
- 资助金额:
$ 12万 - 项目类别:
Effect of anti-S phase agents on human chromosomes
抗S期药物对人类染色体的影响
- 批准号:
8997926 - 财政年份:2013
- 资助金额:
$ 12万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 12万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 12万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 12万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 12万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 12万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 12万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 12万 - 项目类别:
Standard Grant














{{item.name}}会员




